Monitoring Intracellular Oxygen Concentration: Implications for Hypoxia Studies and Real-Time Oxygen Monitoring

  • Michelle Potter
  • Luned Badder
  • Yvette Hoade
  • Iain G. Johnston
  • Karl J. MortenEmail author
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 876)


The metabolic properties of cancer cells have been widely accepted as a hallmark of cancer for a number of years and have shown to be of critical importance in tumour development. It is generally accepted that tumour cells exhibit a more glycolytic phenotype than normal cells. In this study, we investigate the bioenergetic phenotype of two widely used cancer cell lines, RD and U87MG, by monitoring intracellular oxygen concentrations using phosphorescent Pt-porphyrin based intracellular probes. Our study demonstrates that cancer cell lines do not always exhibit an exclusively glycolytic phenotype. RD demonstrates a reliance on oxidative phosphorylation whilst U87MG display a more glycolytic phenotype. Using the intracellular oxygen sensing probe we generate an immediate readout of intracellular oxygen levels, with the glycolytic lines reflecting the oxygen concentration of the environment, and cells with an oxidative phenotype having significantly lower levels of intracellular oxygen. Inhibition of oxygen consumption in lines with high oxygen consumption increases intracellular oxygen levels towards environmental levels. We conclude that the use of intracellular oxygen probes provides a quantitative assessment of intracellular oxygen levels, allowing the manipulation of cellular bioenergetics to be studied in real time.


Intracellular oxygen Mitochondria Oxidative phosphorylation Oxygen probe Aerobic glycolysis 



MP and YH were supported by Williams Fund and LB by Luxcel Biosciences. We would also like to thank Dr James Hynes and Conn Carey (Luxcel Biosciences) and Jasmin Loo and Catherine Wark (BMG Labtech) for technical support.


  1. 1.
    Baynes JW (2009) Chapter 37 “oxygen and life”. In: Baynes JW, Dominiczak MH (eds) Medical biochemistry, 3rd edn. MOSBY Elsevier, Philadelphia.
  2. 2.
    Semenza GL (2007) Life with oxygen. Science 318:62–64CrossRefPubMedGoogle Scholar
  3. 3.
    Vaupel P, Mayer A (2007) Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 26:225–239CrossRefPubMedGoogle Scholar
  4. 4.
    Kondrashina AV, Papkovsky DB, Dmitriev RI (2013) Measurement of cell respiration and oxygenation in standard multichannel biochips using phosphorescent O2-sensitive probes. Analyst 138:4915–4921CrossRefPubMedGoogle Scholar
  5. 5.
    Dmitriev RI, Papkovsky DB (2012) Optical probes and techniques for O2 measurement in live cells and tissue. Cell Mol Life Sci 69:2025–2039CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674CrossRefPubMedGoogle Scholar
  7. 7.
    Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC (2006) HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 3:187–197CrossRefPubMedGoogle Scholar
  8. 8.
    Morten KJ, Badder L, Knowles HJ (2013) Differential regulation of HIF-mediated path ways increases mitochondrial metabolism and ATP production in hypoxic osteoclasts. J Pathol. doi: 10.1002/path.4159 PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, New York 2016

Authors and Affiliations

  • Michelle Potter
    • 1
  • Luned Badder
    • 2
  • Yvette Hoade
    • 1
  • Iain G. Johnston
    • 3
  • Karl J. Morten
    • 1
    Email author
  1. 1.Nuffield Department of Obstetrics and GynaecologyUniversity of OxfordOxfordUK
  2. 2.European Cancer Stem Cell Research Institute, University of CardiffCardiffUK
  3. 3.Department of MathematicsImperial College LondonLondonUK

Personalised recommendations